Cellect LLC v. Vidal — Federal Circuit Affirms Unpatentability of Imaging Device Patent
Cellect, LLC challenged the USPTO's cancellation of US6982742B2, a patent covering hand-held computers with reduced area imaging devices. The Federal Circuit affirmed the unpatentability finding on 28 August 2023, ending a 614-day appellate contest against USPTO Director Katherine K. Vidal.
Cellect's Imaging Patent Fails Federal Circuit Scrutiny
Cellect, LLC filed Case No. 22-1293 on 22 December 2021 before the U.S. Court of Appeals for the Federal Circuit, appealing an administrative determination that US6982742B2 — a patent covering hand-held computers incorporating reduced area imaging devices — was unpatentable. The defendants were Katherine K. Vidal, Director of the USPTO, and Andrew Hirshfeld, represented by USPTO counsel including Thomas W. Krause and Farheena Yasmeen Rasheed.
On 28 August 2023, the Federal Circuit issued a one-line dispositive order: 'AFFIRMED.' The recorded basis of termination is 'Unpatentable,' confirming that the appellate court found no reversible error in the underlying invalidity or cancellation determination. The affirmance is binding and closes Cellect's appellate avenue at this court level for the challenged patent.
The 614-day duration suggests a substantive briefing and argument process before the Federal Circuit. The precise grounds for the original unpatentability finding — whether obviousness-type double patenting, anticipation, or another basis — are not detailed in the available record. The affirmance signals that Cellect's arguments in favour of patentability did not persuade the panel, leaving the patent unenforceable as of the court's ruling.
See Complete Case & Patent Analysis →Filing to Unpatentable in 614 days
614 days from filing to Federal Circuit decision — a substantial appellate proceeding
US6982742B2 — Hand-held computers with reduced area imaging devices
Any organisation developing hand-held computers or portable devices incorporating reduced area imaging technology should assess whether US6982742B2 — or related applications in Cellect's portfolio — creates IP exposure. Although the Federal Circuit has affirmed unpatentability of this specific patent, continuation applications, divisionals, or related family members may remain active. FTO analysis for mobile imaging hardware should extend beyond this single patent number.
Official order — verbatim text
The Federal Circuit's order — 'THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED' — is a standard appellate affirmance disposing of all issues raised by Cellect on appeal. Applied under the applicable standard of review for USPTO patentability determinations, the order confirms the panel found no legal or factual error sufficient to disturb the cancellation ruling below. The unpatentability of US6982742B2 is now a final Federal Circuit determination.
Federal Circuit affirms: what the ruling means for both parties
Affirmance: no reversible error found in the USPTO's ruling
When the Federal Circuit issues an 'AFFIRMED' order in a patentability appeal, it means the appellate panel reviewed the USPTO's cancellation determination and found no reversible legal or factual error. The decision below stands in full. The unpatentability finding is now backed by Federal Circuit authority, giving it substantially heightened precedential weight for any future proceedings involving these claims.
Appellate affirmanceCellect loses its appellate challenge — patent remains unpatentable
The affirmance is a definitive adverse outcome for Cellect, LLC. US6982742B2 is confirmed unpatentable, meaning the claims Cellect sought to enforce or license covering hand-held computers with reduced area imaging devices are no longer valid. Cellect's options at this level are exhausted; further review would require a petition to the U.S. Supreme Court, which is available but rarely granted.
Patent invalidatedUSPTO's cancellation decision upheld in full
The USPTO, represented by Director Vidal and Acting Director Hirshfeld, successfully defended the agency's unpatentability determination at the Federal Circuit. The affirmance validates the USPTO's administrative process and legal reasoning used to cancel the patent. For third parties previously threatened with or subject to claims under US6982742B2, the ruling removes the legal basis for such claims.
Agency prevailsImaging device IP in hand-held computing faces a narrowed landscape
Companies operating in the hand-held computer and reduced area imaging device space — including smartphone, tablet, and wearable manufacturers — benefit from the removal of US6982742B2 as an enforceable asset. The Federal Circuit's affirmance raises the bar for similar patent assertions in this domain and reinforces that USPTO post-grant proceedings can withstand appellate scrutiny. Competitors and licensees should reassess any existing or anticipated obligations linked to this patent.
Claim risk reducedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Cellect, LLC | Company | /Search in Eureka ↗ |
| Defendant | Katherine K. Vidal | Individual | /Search in Eureka ↗ |
| Co-Defendant | Andrew Hirshfeld | Individual | Search in Eureka ↗ |
| Plaintiff counsel | James R. Hannah | Attorney | Counsel for Cellect, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Jeffrey Price | Attorney | Counsel for Cellect, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Jonathan Caplan | Attorney | Counsel for Cellect, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Lisa Kobialka | Attorney | Counsel for Cellect, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Paul J. Andre | Attorney | Counsel for Cellect, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Kramer Levin Naftalis & Frankel, LLP | Law Firm | Representing Cellect, LLCSearch in Eureka ↗ |
| Defendant counsel | Amy J. Nelson | Attorney | Counsel for Katherine K. VidalSearch in Eureka ↗ |
| Defendant counsel | Brian Racilla | Attorney | Counsel for Katherine K. VidalSearch in Eureka ↗ |
| Defendant counsel | Farheena Yasmeen Rasheed | Attorney | Counsel for Katherine K. VidalSearch in Eureka ↗ |
| Defendant counsel | Kakoli Caprihan | Attorney | Counsel for Katherine K. VidalSearch in Eureka ↗ |
| Defendant counsel | Thomas W. Krause | Attorney | Counsel for Katherine K. VidalSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
R&D signals in the hand-held imaging device IP space
Forward-looking patent intelligence derived from Cellect v. Vidal — tracking portfolio activity, filing trends, and white space in hand-held computer and compact imaging technology.
Cellect's imaging portfolio: what remains after US6982742B2
The cancellation of US6982742B2 raises immediate questions about the breadth of Cellect's remaining portfolio in hand-held imaging. Organisations should assess whether Cellect holds continuation or related applications covering overlapping claim scope — particularly those filed on or derived from application US09/935993 — to understand residual licensing or enforcement risk.
Portfolio monitoringFiling trends in reduced area imaging for portable devices
The hand-held imaging space — covering miniaturised cameras and sensors integrated into portable computers — continues to attract significant patent filing activity from consumer electronics and semiconductor firms. Tracking new filings in this domain helps R&D teams anticipate freedom-to-operate constraints and identify where innovation is concentrating post-cancellation of legacy patents like US6982742B2.
Filing trend analysisUSPTO Director's role in shaping post-grant patent validity
The naming of USPTO Director Vidal as defendant signals this case arose from inter partes or ex parte USPTO review proceedings. Tracking how the USPTO has handled similar cancellation actions in imaging and mobile computing reveals broader policy signals for patent holders and challengers alike — particularly around claim construction and double patenting doctrine.
Post-grant intelligenceAdjacent R&D opportunities near cancelled imaging claims
With the claim space of US6982742B2 now vacated, innovators in compact imaging integration for portable devices may find white space for new filings. Advances in computational imaging, sensor miniaturisation for AR/VR wearables, and embedded vision for edge computing represent adjacent areas where differentiated claims could be established without conflicting with the now-cancelled Cellect patent.
White space mappingSimilar Federal Circuit patent validity appeals in mobile imaging
Cases involving Federal Circuit review of USPTO patent cancellation decisions in hand-held computing and imaging device technology — comparable in procedural posture to Cellect v. Vidal.
What this case signals for the imaging device IP landscape
A Federal Circuit affirmance of patent cancellation sends a clear message on validity standards for hand-held imaging device claims.
USPTO post-grant determinations carry significant appellate durability
The Federal Circuit's affirmance of the USPTO's unpatentability finding in Cellect v. Vidal confirms that administrative cancellation proceedings are difficult to overturn on appeal. Patent owners asserting imaging device IP in hand-held computing should scrutinise claim robustness before pursuing enforcement or litigation.
Competitors in hand-held imaging can operate with reduced freedom-to-operate risk
With US6982742B2 confirmed unpatentable, manufacturers and developers of hand-held computers incorporating reduced area imaging devices face a lower IP barrier from this specific patent family. Ongoing FTO analysis should still account for continuation or related applications Cellect may hold.
Cellect v Katherine — key questions answered
The Federal Circuit affirmed the unpatentability of US6982742B2, a patent held by Cellect, LLC covering hand-held computers incorporating reduced area imaging devices. The court's order, issued 28 August 2023, found no reversible error in the USPTO's cancellation determination. The basis of termination is recorded as 'Unpatentable.'
The patent at issue was US6982742B2 (application number US09/935993), covering hand-held computers incorporating reduced area imaging devices. The patent was asserted by Cellect, LLC and had been found unpatentable by the USPTO before Cellect appealed to the Federal Circuit.
The Federal Circuit's affirmance confirms the USPTO's finding that US6982742B2 is unpatentable. The patent can no longer be enforced. Third parties previously subject to licensing demands or infringement assertions based on this patent are no longer at risk from this specific asset. Related applications in Cellect's portfolio are not addressed by this ruling.
Cellect, LLC was represented by Kramer Levin Naftalis & Frankel, LLP. Named counsel included Paul J. Andre, Lisa Kobialka, Jonathan Caplan, James R. Hannah, and Jeffrey Price. The USPTO was represented by counsel including Thomas W. Krause, Farheena Yasmeen Rasheed, Kakoli Caprihan, Brian Racilla, and Amy J. Nelson.
Following a Federal Circuit affirmance, the remaining avenue for further review is a petition for certiorari to the U.S. Supreme Court. The Supreme Court grants certiorari in a very small fraction of cases. The specific terms of any further appellate strategy Cellect may pursue are not disclosed in the available record.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.